Fenofibrate as an adjunct to statins was associated with lower risks for all-cause mortality and cardiovascular disease among individuals with type 2 diabetes. Fenofibrate as an adjunct to statin ...
—Recent studies suggest that a hospitalization related to cardiovascular events can follow a hospitalization for chronic obstructive pulmonary disease. But have these studies been too broad? No ...
Among older adults with established ASCVD, hospitalization for COPD increases risk of ASCVD hospitalization. The risk for atherosclerotic cardiovascular disease (ASCVD) hospitalization after chronic ...
Patients with both diabetes and atherosclerotic cardiovascular disease (ASCVD) have about 1.5 times higher total direct health care expenditures than those without diabetes. However, limited studies ...
Researchers found that the cumulative incidence of MI, stroke, and 10-year all-cause mortality was significantly lower in the ASA group vs the no-ASA group (42.4 vs 61.2%, 14.5 vs 24.8%, and 33 vs ...
DALLAS, Dec. 16, 2025 — There is increasing evidence that gum disease is associated with increased risk of cardiovascular events, including heart attack, stroke, atrial fibrillation, heart failure and ...
Enlicitide, designed to deliver antibody-like efficacy, has the potential to be the first approved oral PCSK9 inhibitor to lower LDL-C with a safety profile comparable to placebo Enlicitide may help ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback